What changed
Comparing the January 2023 edition with December 2022.
Showing all 143 changes.
Added (42)
Agreement versions that appear in this edition but not the last. A "new version of an existing agreement" is usually a renewal or amendment of something already in the register.
Amended (99)
Agreement versions whose details changed in place — a revised purpose, a different end date, a change to the datasets listed, or a benefits statement that has been filled in. NHS England issues no new version number for these and publishes no changelog; they are found by comparing one edition with the last.
Changes here are counted only where the wording itself moved. An edition that reformats text — different quote characters, spacing or capitalisation — no longer counts as an amendment.
| Agreement | Organisation | Reference | What changed |
|---|---|---|---|
| Real-world effectiveness of the Oxford/AstraZeneca covid-19 vaccine in England - TRE Analysis | AstraZeneca UK Limited | DARS-NIC-445543-W0D4N-v0.7 |
|
| Real-world effectiveness of the Oxford/AstraZeneca covid-19 vaccine in England - TRE Analysis | AstraZeneca UK Limited | DARS-NIC-445543-W0D4N-v1.2 |
|
| Real-world effectiveness of the Oxford/AstraZeneca covid-19 vaccine *** and investigation of the epidemiology of thrombotic thrombocytopenia and other adverse events of interest following COVID-19 vaccination*** in England - TRE Analysis | AstraZeneca UK Limited | DARS-NIC-445543-W0D4N-v2.2 |
|
| Real-world effectiveness of the Oxford/AstraZeneca covid-19 vaccine *** and investigation of the epidemiology of thrombotic thrombocytopenia and other adverse events of interest following COVID-19 vaccination*** in England - TRE Analysis | AstraZeneca UK Limited | DARS-NIC-445543-W0D4N-v3.4 |
|
| Real-world effectiveness and safety of the Oxford/AstraZeneca covid-19 vaccine in England: ORCHID linkage | AstraZeneca UK Limited | DARS-NIC-459114-J3C1F-v0.5 |
|
| Real-world effectiveness and safety of the Oxford/AstraZeneca covid-19 vaccine ***and investigation of the epidemiology of thrombotic thrombocytopenia and other adverse events of interest following COVID-19 vaccination*** in England: ORCHID linkage | AstraZeneca UK Limited | DARS-NIC-459114-J3C1F-v1.4 |
|
| The impact of COVID-19 on surgical care and outcomes in England (COVID-19 Surgical Observatory) - project 2 | Barts Health NHS Trust | DARS-NIC-400985-V3D1C-v0.17 |
|
| Mental Health of Children and Young People Survey (MHCYP) | Children's Commissioner's Office | DARS-NIC-354267-B4V2G-v0.7 |
|
| Health Burden of COVID-19 and Healthcare Resource Utilisation in England | Evidera Ltd | DARS-NIC-561357-X0F3N-v0.21 |
|
| Genomics England (MR1418) - Renewal Request for tranche of data across multiple data sets. | Genomics England | DARS-NIC-12784-R8W7V-v11.2 |
|
| R26 - GENOMICS ENGLAND: GenOMICC COVID-19 Study | Genomics England | DARS-NIC-374190-D0N1M-v0.4 |
|
| R26 - GENOMICS ENGLAND: GenOMICC COVID-19 Study | Genomics England | DARS-NIC-374190-D0N1M-v1.3 |
|
| R26 - GENOMICS ENGLAND: GenOMICC COVID-19 Study | Genomics England | DARS-NIC-374190-D0N1M-v2.3 |
|
| R26 - GENOMICS ENGLAND: GenOMICC COVID-19 Study | Genomics England | DARS-NIC-374190-D0N1M-v3.2 |
|
| R26 - GENOMICS ENGLAND: GenOMICC COVID-19 Study | Genomics England | DARS-NIC-374190-D0N1M-v4.1 |
|
| R26 - GENOMICS ENGLAND: GenOMICC COVID-19 Study | Genomics England | DARS-NIC-374190-D0N1M-v5.5 |
|
| Epidemiology and Prognosis in Acute Myocarditis | Guy's and St Thomas' NHS Foundation Trust | DARS-NIC-144568-D7G6V-v3.4 |
|
| Harvey Walsh Ltd - data dissemination | Harvey Walsh Ltd | DARS-NIC-05934-M7V9K-v12.3 |
|
| Harvey Walsh Ltd - data dissemination | Harvey Walsh Ltd | DARS-NIC-05934-M7V9K-v13.4 |
|
| R14.2 - CVD-COVID-UK. Cardiovascular disease and COVID-19: using UK-wide linked routine healthcare data to address the impact of cardiovascular disease on COVID-19 and the impact of COVID-19 on cardiovascular diseases. | Health Data Research UK | DARS-NIC-381078-Y9C5K-v0.10 |
|
| R14.2 - CVD-COVID-UK. Cardiovascular disease and COVID-19: using UK-wide linked routine healthcare data to address the impact of cardiovascular disease on COVID-19 and the impact of COVID-19 on cardiovascular diseases. | Health Data Research UK | DARS-NIC-381078-Y9C5K-v1.2 |
|
| R14.2 - CVD-COVID-UK. Cardiovascular disease and COVID-19: using UK-wide linked routine healthcare data to address the impact of cardiovascular disease on COVID-19 and the impact of COVID-19 on cardiovascular diseases. | Health Data Research UK | DARS-NIC-381078-Y9C5K-v2.2 |
|
| R14.2 - CVD-COVID-UK. Cardiovascular disease and COVID-19: using UK-wide linked routine healthcare data to address the impact of cardiovascular disease on COVID-19 and the impact of COVID-19 on cardiovascular diseases. | Health Data Research UK | DARS-NIC-381078-Y9C5K-v3.3 |
|
| R14.2 - CVD-COVID-UK. Cardiovascular disease and COVID-19: using UK-wide linked routine healthcare data to address the impact of cardiovascular disease on COVID-19 and the impact of COVID-19 on cardiovascular diseases. | Health Data Research UK | DARS-NIC-381078-Y9C5K-v4.4 |
|
| R14.2 - CVD-COVID-UK. Cardiovascular disease and COVID-19: using UK-wide linked routine healthcare data to address the impact of cardiovascular disease on COVID-19 and the impact of COVID-19 on cardiovascular diseases. | Health Data Research UK | DARS-NIC-381078-Y9C5K-v5.4 |
|
| R14.2 - COVID-IMPACT-UK. Cardiovascular disease and COVID-19: using UK-wide linked routine healthcare data to address the impact of cardiovascular disease on COVID-19 and the impact of COVID-19 on cardiovascular diseases. | Health Data Research UK | DARS-NIC-381078-Y9C5K-v6.2 |
|
| R14.2 - COVID-IMPACT-UK. Cardiovascular disease and COVID-19: using UK-wide linked routine healthcare data to address the impact of cardiovascular disease on COVID-19 and the impact of COVID-19 on cardiovascular diseases. | Health Data Research UK | DARS-NIC-381078-Y9C5K-v7.2 |
|
| COVID Oximetry At Home - (CO@H): Imperial | Imperial College London | DARS-NIC-421524-R0Y3P-v0.4 |
|
| COVID Oximetry At Home - (CO@H): Imperial | Imperial College London | DARS-NIC-421524-R0Y3P-v1.3 |
|
| COVID Oximetry At Home - (CO@H): Imperial | Imperial College London | DARS-NIC-421524-R0Y3P-v2.3 |
|
| Imperial College London - REACT Data and Connectivity National Core Studies | Imperial College London | DARS-NIC-431352-G7F1M-v0.4 |
|
| R23 - Clinical Practice Research Datalink (CPRD) Routine Linkages Application | Medicines and Healthcare Products Regulatory Agency (MHRA) | DARS-NIC-15625-T8K6L-v10.4 |
|
| R23 - Clinical Practice Research Datalink (CPRD) Routine Linkages Application | Medicines and Healthcare Products Regulatory Agency (MHRA) | DARS-NIC-15625-T8K6L-v11.2 |
|
| R23 - Clinical Practice Research Datalink (CPRD) Routine Linkages Application | Medicines and Healthcare Products Regulatory Agency (MHRA) | DARS-NIC-15625-T8K6L-v7.1 |
|
| R23 - Clinical Practice Research Datalink (CPRD) Routine Linkages Application | Medicines and Healthcare Products Regulatory Agency (MHRA) | DARS-NIC-15625-T8K6L-v8.2 |
|
| R23 - Clinical Practice Research Datalink (CPRD) Routine Linkages Application | Medicines and Healthcare Products Regulatory Agency (MHRA) | DARS-NIC-15625-T8K6L-v9.2 |
|
| Patterning of children and young peoples' mental health before and in the context of Covid-19: findings from the 2017 Mental Health of Children and Young People survey and the 2020 MHCYP Covid-19 follow up survey | Natcen Social Research | DARS-NIC-404798-C1Z9R-v0.6 |
|
| R11 - Convalescent Plasma Program (Serum trial) | NHS Blood and Transplant (NHSBT) | DARS-NIC-372791-X0H3Q-v0.2 |
|
| R11.1 - Convalescent Plasma Program (Serum trial) | NHS Blood and Transplant (NHSBT) | DARS-NIC-372791-X0H3Q-v1.2 |
|
| R11, R11.1, R11.2 - Convalescent Plasma Program (Serum trial) | NHS Blood and Transplant (NHSBT) | DARS-NIC-372791-X0H3Q-v2.3 |
|
| R11, R11.1, R11.2 - Convalescent Plasma Program (Serum trial) | NHS Blood and Transplant (NHSBT) | DARS-NIC-372791-X0H3Q-v3.3 |
|
| COVID-19 – NHS England Application | NHS England (Quarry House) | DARS-NIC-384608-C9B4L-v2.2 |
|
| COVID-19 – NHS England Application | NHS England (Quarry House) | DARS-NIC-384608-C9B4L-v3.2 |
|
| COVID-19 – NHS England Application | NHS England (Quarry House) | DARS-NIC-384608-C9B4L-v4.2 |
|
| COVID-19 – NHS England Application | NHS England (Quarry House) | DARS-NIC-384608-C9B4L-v5.2 |
|
| COVID-19 – NHS England Application | NHS England (Quarry House) | DARS-NIC-384608-C9B4L-v6.2 |
|
| Request for remote access to data in NHS Digital’s environment for COVID-19 purposes | Office for National Statistics (ONS) | DARS-NIC-388794-Z9P3J-v2.3 |
|
| Request for remote access to data in NHS Digital’s environment for COVID-19 purposes | Office for National Statistics (ONS) | DARS-NIC-388794-Z9P3J-v3.2 |
|
| Request for remote access to data in NHS Digital’s environment for COVID-19 purposes | Office for National Statistics (ONS) | DARS-NIC-388794-Z9P3J-v4.2 |
|
| Request for remote access to data in NHS Digital’s environment for COVID-19 purposes | Office for National Statistics (ONS) | DARS-NIC-388794-Z9P3J-v5.4 |
|
| Request for remote access to data in NHS Digital’s environment for COVID-19 purposes | Office for National Statistics (ONS) | DARS-NIC-388794-Z9P3J-v6.3 |
|
| COVIDENCE/CORONAVIT - 1141 - 12/05/2021 16:46 | Queen Mary University of London | DARS-NIC-449801-W5J4M-v0.10 |
|
| COVIDENCE/CORONAVIT - 1141 - 12/05/2021 16:46 | Queen Mary University of London | DARS-NIC-449801-W5J4M-v1.1 |
|
| COVID Oximetry At Home - (CO@H): Improvement Analytics Unit | The Health Foundation | DARS-NIC-421528-J6S3N-v0.4 |
|
| COVID Oximetry At Home - (CO@H): Improvement Analytics Unit | The Health Foundation | DARS-NIC-421528-J6S3N-v1.3 |
|
| D1.1 - PHE Single Data Sharing Agreement | UK Health Security Agency | DARS-NIC-343380-H5Q9K-v15.1 |
|
| D24 - Request to share data for Covid-19 purposes – HOSTED Project | UK Health Security Agency | DARS-NIC-381634-X8H0H-v0.3 |
|
| D24 - Request to share data for Covid-19 purposes – HOSTED Project | UK Health Security Agency | DARS-NIC-381634-X8H0H-v1.2 |
|
| D24 - Request to share data for Covid-19 purposes – HOSTED Project | UK Health Security Agency | DARS-NIC-381634-X8H0H-v2.2 |
|
| D24 - Request to share data for Covid-19 purposes – HOSTED Project | UK Health Security Agency | DARS-NIC-381634-X8H0H-v3.4 |
|
| D24 - Request to share data for Covid-19 purposes – HOSTED Project | UK Health Security Agency | DARS-NIC-381634-X8H0H-v4.5 |
|
| Prevalence, clinical characteristics and impact of body dysmorphic disorder in young people | University College London (UCL) | DARS-NIC-259538-Q4V0W-v0.15 |
|
| Virus Watch: Understanding community incidence, symptom profiles, and transmission of COVID-19 in relation to population movement and behaviour | University College London (UCL) | DARS-NIC-372269-N8D7Z-v0.3 |
|
| Virus Watch: Understanding community incidence, symptom profiles, and transmission of COVID-19 in relation to population movement and behaviour | University College London (UCL) | DARS-NIC-372269-N8D7Z-v1.6 |
|
| NIHR Children and Families Policy Research Unit | University College London (UCL) | DARS-NIC-393510-D6H1D-v6.11 |
|
| NIHR Children and Families Policy Research Unit | University College London (UCL) | DARS-NIC-393510-D6H1D-v7.1 |
|
| University of Bristol - Longitudinal Linkage Collaboration | University of Bristol | DARS-NIC-420168-K4N1F-v0.11 |
|
| University of Bristol - Longitudinal Linkage Collaboration | University of Bristol | DARS-NIC-420168-K4N1F-v1.2 |
|
| University of Bristol - Longitudinal Linkage Collaboration | University of Bristol | DARS-NIC-420168-K4N1F-v2.5 |
|
| University of Bristol - Longitudinal Linkage Collaboration | University of Bristol | DARS-NIC-420168-K4N1F-v3.2 |
|
| Tracking the impact of Covid-19 on the mental health of children, young people and families; follow up of a national longitudinal probability sample: follow-on interviews | University of Exeter | DARS-NIC-402080-N3V5Z-v0.5 |
|
| Tracking the impact of Covid-19 on the mental health of children, young people and families; follow up of a national longitudinal probability sample: follow-on interviews | University of Exeter | DARS-NIC-402080-N3V5Z-v1.3 |
|
| Tracking the impact of Covid-19 on the mental health of children, young people and families; follow up of a national longitudinal probability sample: follow-on interviews | University of Exeter | DARS-NIC-402080-N3V5Z-v2.3 |
|
| Understanding Time Trends in Child and Adolescent Mental Health: Impact of Covid-19 | University of Exeter | DARS-NIC-424336-T7K7T-v0.6 |
|
| ISARIC4C Coronavirus Clinical Information Network (COCIN) GPES record linkage | University of Liverpool | DARS-NIC-402963-P0Y5D-v0.2 |
|
| ISARIC4C Coronavirus Clinical Information Network (COCIN) GPES record linkage | University of Liverpool | DARS-NIC-402963-P0Y5D-v1.8 |
|
| Protect-CH: Prophylactic Therapy in Care Homes Trial | University of Nottingham | DARS-NIC-437579-V8J5V-v0.6 |
|
| R1 (D09) - Data support to COVID-19 RCT | University of Oxford | DARS-NIC-365354-R3M0Q-v2.2 |
|
| R1 (D09) - Data support to COVID-19 RCT | University of Oxford | DARS-NIC-365354-R3M0Q-v3.3 |
|
| R1 (D09) - Data support to COVID-19 RCT | University of Oxford | DARS-NIC-365354-R3M0Q-v4.2 |
|
| R1 (D09) - Data support to COVID-19 RCT | University of Oxford | DARS-NIC-365354-R3M0Q-v5.6 |
|
| R1 (D09) - Data support to COVID-19 RCT | University of Oxford | DARS-NIC-365354-R3M0Q-v6.3 |
|
| R1 (D09) - Data support to COVID-19 RCT | University of Oxford | DARS-NIC-365354-R3M0Q-v7.3 |
|
| R1 (D09) - Data support to COVID-19 RCT | University of Oxford | DARS-NIC-365354-R3M0Q-v8.2 |
|
| R1 (D09) - Data support to COVID-19 RCT (RECOVERY) | University of Oxford | DARS-NIC-365354-R3M0Q-v9.5 |
|
| RCGP Research Surveillance Network Observational Research Umbrella (RCGP RSC ORUm) | University of Oxford | DARS-NIC-381683-R6R6K-v0.2 |
|
| RCGP Research Surveillance Network Observational Research Umbrella (RCGP RSC ORUm) | University of Oxford | DARS-NIC-381683-R6R6K-v1.2 |
|
| QResearch - COVID-19 Risk Stratification project | University of Oxford | DARS-NIC-382794-T3L3M-v2.5 |
|
| QResearch - COVID-19 Risk Stratification project | University of Oxford | DARS-NIC-382794-T3L3M-v3.1 |
|
| QResearch - COVID-19 Risk Stratification project | University of Oxford | DARS-NIC-382794-T3L3M-v4.2 |
|
| QResearch - COVID-19 Risk Stratification project | University of Oxford | DARS-NIC-382794-T3L3M-v5.4 |
|
| QResearch-Oxford Data Linkage Project | University of Oxford | DARS-NIC-382794-T3L3M-v6.7 |
|
| RAPid Testing fOR Covid-19 (RAPTOR-C19). | University of Oxford | DARS-NIC-396119-C8W3W-v0.4 |
|
| National Core Studies - Data and Connectivity: COVID-19 Vaccines Pharmacovigilance (DaC-VaP) | University of Oxford | DARS-NIC-431355-B1L8W-v0.9 |
|
| National Core Studies - Data and Connectivity: COVID-19 Vaccines Pharmacovigilance (DaC-VaP) | University of Oxford | DARS-NIC-431355-B1L8W-v1.3 |
|
| University of Oxford- National Core Studies Can phenotypes developed from enhanced remote primary care assessment of COVID-19 be used to identify a cohort of community cases, and enable comparison of recovered and long COVID? | University of Oxford | DARS-NIC-431881-N8B0N-v0.12 |
|
| University of Oxford- National Core Studies Can phenotypes developed from enhanced remote primary care assessment of COVID-19 be used to identify a cohort of community cases, and enable comparison of recovered and long COVID? | University of Oxford | DARS-NIC-431881-N8B0N-v1.6 |
|
| University of Oxford- National Core Studies Can phenotypes developed from enhanced remote primary care assessment of COVID-19 be used to identify a cohort of community cases, and enable comparison of recovered and long COVID? | University of Oxford | DARS-NIC-431881-N8B0N-v2.2 |
|
| Astrazeneca/Oxford - Re-use of existing data for data validation exercise | University of Oxford | DARS-NIC-480562-G9R5X-v0.2 |
|
No longer listed (2)
Present in the previous edition and absent from this one. This usually means an expired agreement has been retired from the published register rather than anything being withdrawn. An agreement that has left entirely keeps its page here, marked as no longer in the register.
Editions processed
Every edition below has its own "what changed" page against the one before it — not just the latest.
- July 2021 — 2,682 agreement versions, retrieved 20 September 2026
- August 2021 — 2,719 agreement versions, retrieved 20 September 2026
- September 2021 — 2,754 agreement versions, retrieved 20 September 2026
- October 2021 — 2,849 agreement versions, retrieved 20 September 2026
- November 2021 — 2,932 agreement versions, retrieved 20 September 2026
- December 2021 — 2,999 agreement versions, retrieved 20 September 2026
- January 2022 — 3,063 agreement versions, retrieved 20 September 2026
- February 2022 — 3,124 agreement versions, retrieved 20 September 2026
- March 2022 — 3,170 agreement versions, retrieved 20 September 2026
- April 2022 — 3,217 agreement versions, retrieved 20 September 2026
- May 2022 — 3,283 agreement versions, retrieved 20 September 2026
- June 2022 — 3,345 agreement versions, retrieved 20 September 2026
- July 2022 — 3,386 agreement versions, retrieved 20 September 2026
- August 2022 — 3,414 agreement versions, retrieved 20 September 2026
- September 2022 — 3,451 agreement versions, retrieved 20 September 2026
- October 2022 — 3,474 agreement versions, retrieved 20 September 2026
- November 2022 — 3,499 agreement versions, retrieved 20 September 2026
- December 2022 — 3,570 agreement versions, retrieved 20 September 2026
- January 2023 — 3,610 agreement versions, retrieved 20 September 2026
- February 2023 — 3,583 agreement versions, retrieved 20 September 2026
- March 2023 — 3,619 agreement versions, retrieved 20 September 2026
- April 2023 — 3,664 agreement versions, retrieved 20 September 2026
- May 2023 — 3,702 agreement versions, retrieved 20 September 2026
- June 2023 — 3,752 agreement versions, retrieved 20 September 2026
- July 2023 — 3,795 agreement versions, retrieved 20 September 2026
- August 2023 — 3,843 agreement versions, retrieved 20 September 2026
- September 2023 — 3,893 agreement versions, retrieved 20 September 2026
- October 2023 — 3,927 agreement versions, retrieved 20 September 2026
- November 2023 — 3,960 agreement versions, retrieved 20 September 2026
- December 2023 — 4,006 agreement versions, retrieved 20 September 2026
- January 2024 — 4,057 agreement versions, retrieved 20 September 2026
- February 2024 — 4,108 agreement versions, retrieved 20 September 2026
- March 2024 — 4,145 agreement versions, retrieved 20 September 2026
- April 2024 — 4,186 agreement versions, retrieved 20 September 2026
- May 2024 — 4,239 agreement versions, retrieved 20 September 2026
- June 2024 — 4,364 agreement versions, retrieved 20 September 2026
- July 2024 — 4,440 agreement versions, retrieved 20 September 2026
- August 2024 — 4,488 agreement versions, retrieved 20 September 2026
- September 2024 — 4,537 agreement versions, retrieved 20 September 2026
- October 2024 — 4,559 agreement versions, retrieved 20 September 2026
- November 2024 — 4,615 agreement versions, retrieved 20 September 2026
- December 2024 — 4,656 agreement versions, retrieved 20 September 2026
- January 2025 — 4,698 agreement versions, retrieved 20 September 2026
- February 2025 — 4,749 agreement versions, retrieved 20 September 2026
- March 2025 — 4,790 agreement versions, retrieved 20 September 2026
- April 2025 — 4,848 agreement versions, retrieved 20 September 2026
- May 2025 — 4,901 agreement versions, retrieved 20 September 2026
- June 2025 — 4,960 agreement versions, retrieved 20 September 2026
- July 2025 — 5,012 agreement versions, retrieved 20 September 2026
- August 2025 — 5,057 agreement versions, retrieved 20 September 2026
- September 2025 — 5,096 agreement versions, retrieved 20 September 2026
- October 2025 — 5,147 agreement versions, retrieved 20 September 2026
- November 2025 — 5,194 agreement versions, retrieved 20 September 2026
- December 2025 — 5,231 agreement versions, retrieved 20 September 2026
- January 2026 — 5,263 agreement versions, retrieved 20 September 2026
- February 2026 — 5,318 agreement versions, retrieved 20 September 2026
- March 2026 — 5,343 agreement versions, retrieved 20 September 2026
- April 2026 — 5,390 agreement versions, retrieved 20 September 2026
- May 2026 — 5,443 agreement versions, retrieved 20 September 2026
- June 2026 — 5,487 agreement versions, retrieved 20 September 2026
- July 2026 — 5,546 agreement versions, retrieved 20 September 2026
- August 2026 — 5,577 agreement versions, retrieved 20 September 2026
- September 2026 Current — 5,613 agreement versions, retrieved 20 September 2026